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the Asymptomatic Carotid Atherosclerosis Study2
(ACAS). These studies also documented the high inci-
dence rate of medical comorbidity in this population.
In particular, coronary artery disease was the most
prevalent medical risk factor and was identified in 58%
and 69% of patients in the VACS and ACAS studies,
respectively. The impact of cardiovascular disease in
both studies was reflected in the mortality rate statis-
tics: 20% of the deaths in the VACS and 49% in the
ACAS were results of cardiac causes, with myocardial
infarction accounting for about half of these deaths.
The ACAS study showed a stroke/mortality rate
of 5% in the operated group versus 11% for medical-
ly treated cases in a 5-year period. In the design and
analysis of the trial, the authors acknowledge the
requirement of low perioperative morbidity and
mortality rates to confer benefit from surgery in
patients who are asymptomatic. In support of this
conclusion, a survey of 1511 CEAs performed by
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Carotid endarterectomy (CEA) is a commonly
performed vascular procedure. The efficacy of CEA 
for patients who are asymptomatic with carotid bifur-
cation atherosclerosis has been quantified in the
Veterans Affairs Cooperative Study1 (VACS) and 
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Purpose: Myocardial infarction and other comorbidities contribute to complications after
carotid endarterectomy (CEA). However, because the combined stroke and death rate
after CEA is less than 5%, even relatively large series have small numbers of adverse events
that preclude a detailed analysis of the association between the outcome and the patient
factors, such as comorbidity and age. We sought to overcome this limitation by studying
patients who underwent CEA in a large random sample of Medicare beneficiaries.
Methods: We used a database that contained a 20% random sample of all Medicare bene-
ficiaries to identify patients who underwent CEA between the years 1988 to 1990 (n =
22,165), and we followed these cases until 1992. With multivariate logistic regression
and Cox proportional hazards regression models, we examined the impact of age, race,
gender, geographic location, hospital characteristics, and comorbidity, including acute
myocardial infarction (AMI) and congestive heart failure (CHF), on the risk of stroke
and death after CEA.
Results: AMI and CHF had the greatest negative impact on the long-term survival rates
(adjusted hazard ratio [HR]: 2.40, P < .0001, and 2.85, P < .0001, respectively). Other
variables with a significant impact on the long-term survival rates were an age of >80
years (HR, 2.16; P < .0001), an acute stroke (HR, 1.51; P < .0001), diabetes mellitus
(DM; HR, 1.52; P < .0001), and male sex (HR, 1.32; P < .0001). In addition, AMI,
CHF, DM, and advanced age were associated with an increased risk of perioperative
stroke and death.
Conclusion: Patients with AMI, CHF, DM, and an age of >80 years have diminished
perioperative and long-term survival rates after CEA. These results may alter the
risk/benefit analysis for such patients, especially those with asymptomatic disease. 
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the ACAS participating surgeons revealed a
stroke/mortality rate of 1.7%.3 This observation
highlights the potential importance of medical
comorbidity on outcome, particularly in patients
with asymptomatic carotid disease.
The benefits of CEA in patients who are asymp-
tomatic are realized over time. Those patients with
significant comorbidity and increased operative risk
or diminished life expectancy may not accrue a sig-
nificant reduction in stroke risk. These issues are
addressed in a multidisciplinary consensus statement
from the American Heart Association.4 The authors
state that CEA for patients who are asymptomatic
with critical carotid stenosis is appropriate if the
stroke/mortality rate is less than 3% and inappropri-
ate if the stroke/mortality rate is more than 6%. The
prevalence of pre-existing coronary artery disease and
its contribution to postoperative death by myocardial
infarction may be among the major factors that
determine the outcome and the benefits of CEA.
In addition to coronary artery disease, patients
with carotid atherosclerosis have a high prevalence
of other illnesses, such as hypertension and diabetes
mellitus5 (DM), and attempts have been made to
quantify the impact of these comorbidities and other
factors on the outcome after CEA. A recent study
found an association of death within 3 years after
CEA with ischemic heart disease and DM.6 Perler7
examined the outcome after CEA in elderly patients
and found no differences in early results, with
respect to age, but long-term data were not avail-
able. In light of the low incidence rate of stroke and
death after CEA, most of these studies have insuffi-
cient numbers of patients with those endpoints to
adequately examine the association between comor-
bid disease and adverse events.
We sought to examine the impact of comorbidi-
ty and demographic factors on early and late out-
come after CEA with a large sample of Medicare
beneficiaries. We focused on the presence of myocar-
dial infarction and other common risk factors associ-
ated with atherosclerosis. These parameters, along
with age, demographic variables, other comorbid ill-
nesses, and hospital characteristics, were assessed for
their impact on the early stroke and death rates (ie,
within 30 days of CEA) and on late mortality rates.
With multivariate logistic regression and Cox pro-
portional hazards regression models, we quantified
the relative contributions of each parameter on the
endpoints examined. 
METHODS
Data sources. We selected our sample from the
Health Care Financing Administration (HCFA)
Medical Provider Analysis and Review (MEDPAR)
files, which contain a random sample of approxi-
mately 20% of all Medicare beneficiaries with part A
coverage during 1988, 1989, and 1990. The ran-
domization process was on the basis of the last digit
of a beneficiary’s social security number. Each
record in the data set represents an admission to a
hospital and contains up to five diagnostic codes and
up to three procedure codes from the International
Classification of Disease, Ninth Revision, Clinical
Modification (ICD-9-CM). The diagnostic codes do
not contain information regarding the laterality of a
procedure or event (ie, right versus left). We also
obtained each patient’s age, race, gender, and state
of residence from this data set.
We used unique patient and hospital identifiers
to link MEDPAR files with HCFA’s Health
Insurance Skeleton Eligibility Write-off file to obtain
the date of death for all patients who died during the
study period (1988 to 1992). The Health Insurance
Skeleton Eligibility Write-off file reflects account
information that is updated at the time of a patient’s
death and, therefore, reliably captures all deaths in
the study population without regard to cause. We
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Table I. Patients excluded from analysis
Reason for exclusion No. Percent of original sample
Race unknown or other 937 3.9
No coding for carotid stenosis 598 2.5
CEA during previous year (1988 patients) 162 0.7
No information on hospital teaching status 47 0.2
Date of death unknown 14 < 0.1
No information on number of hospital beds 11 < 0.1
Missing other data 15 < 0.1
Total 1625* 6.8
CEA, Carotid endarterectomy.
*Some patients were missing more than 1 parameter.
used HCFA’s Provider of Service file to obtain the
number of resident trainees and the number of beds
at each hospital represented in the sample.
Patient sample. We selected patients who were
66 years of age or older with an ICD-9-CM proce-
dure code of 38.12 (endarterectomy of the vessels of
the head and the neck other than intracranial vessels)
and a diagnosis code of 433 (occlusion or stenosis of
the precerebral arteries) in the years 1988, 1989, and
1990 (n = 23,730). The earliest occurrence of this
event was designated as the index procedure. For
those patients with an index procedure in 1988, we
excluded patients (<1.0%) with a procedure code of
38.12 during the year before their 1988 procedure
date. We did this to remove patients who might have
had early re-exploration after a previous CEA. We also
excluded patients whose residence was not in 1 of the
50 states or the District of Columbia, whose race was
listed as something other than black or white, and
whose information on date of death, number of resi-
dent trainees at treating hospital, or number of beds
at treating hospital was missing. After exclusions,
22,165 patients met eligibility criteria (Table I). 
Variable definitions. We coded indications for
the index CEA as transient ischemic attack/amauro-
sis fugax (ICD-9-CM codes 435 or 362.34), stroke
(codes 434, 436, or 437), and stenosis (code 433).
We created indicators for comorbid disease by
searching ICD-9-CM codes for acute myocardial
infarction (code 410), congestive heart failure
(codes 398.91, 402.01, 402.11, 402.91, 404.01,
404.03, 404.11, 404.13, 404.91, 404.93, or 428),
other cardiovascular disease (codes 411-414 or
429.2), hypertension (codes 401-405, excluding the
congestive heart failure codes mentioned above),
diabetes (code 250), atherosclerosis (code 440), and
malignant disease (codes 140-239). We also created
an indicator for coronary artery bypass graft surgery
(CAB; procedure codes 35.2, 35.3, and 36.1) that
occurred on the same day as the CEA. Each patient’s
state of residence was coded into 1 of the following
4 census regions: west, midwest, southeast, and
northeast. Hospital teaching status was determined
from the ratio of the number of the resident trainees
in a hospital to the number of the beds and classified
as major (ratio >0.25), minor (ratio >0 and <0.25),
or nonteaching (ratio = 0).
Statistical analysis. All analyses were conducted
with SAS software (SAS/Stat, Release 6.12, SAS
Institute, Cary, NC). We used logistic regression
analysis to examine the influence of acute myocardial
infarction (AMI), congestive heart failure (CHF),
and CAB during the index admission on both death
and stroke rates within 30 days of the index proce-
dure. Other covariates in the models included
patient demographic characteristics, indications for
surgery, other comorbid conditions, and hospital
characteristics. The reported odds ratios were adjust-
ed for all of the variables in the models. Each model
satisfied the goodness-of-fit criteria proposed by
Hosmer and Lemeshow.8
We used the Cox proportional hazards regres-
sion model to examine the influence of the variables
of interest on death rates through 1992, controlling
for the covariates listed above. Analysis of the resid-
uals from the fitted data using the SAS software
guidelines confirmed adequacy of the model.9
RESULTS
Characteristics of patient sample. Table II out-
lines the demographic and comorbidity characteristics
of the study population. There was a slight prepon-
derance of men (56.7%). Nearly 10% of the patients
were first seen with a recent stroke, and 16.6% had
transient ischemic attack (TIA) as one of the admitting
diagnoses, which represented a combined proportion
of 26.2% for patients with symptomatic carotid disease.
Hypertension (34.8%), DM (14.6%), cardiovascular
disease (28%), and CHF (3.7%) were the major
comorbid conditions coded in the admitting diag-
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Table II. Prevalence of demographic and comor-




66 to 70 6959 31.4
71 to 75 7365 33.2
76 to 80 5153 23.2
>80 2688 12.1
Female sex 9587 43.3
Black race 538 2.4
Hypertension 7711 34.8
Diabetes mellitus 3242 14.6
Atherosclerosis 1357 6.1
Acute myocardial infarction 315 1.4
Congestive heart failure 817 3.7
Other Cardiovascular disease 5993 27
Malignant disease 448 2
TIA or amaurosis 3680 16.6
Recent stroke 2122 9.6






TIA, transient ischemic attack; CAB, Coronary artery bypass
graft; CEA, carotid endarterectomy.
noses. Patients who underwent simultaneous coronary
bypass grafting and CEA (2.1%) represented a small
sample of the group. The geographic region with the
largest number of patients was the southeast (38.4%)
and the smallest was the northeast (15.8%).
Perioperative morbidity and mortality rates.
Overall, the rates of stroke and death within 30 days
of the operation were 2.4% and 2.3%, respectively,
which represents a combined rate of 4.7%. Table III
shows the relationship between the demographic
and comorbidity parameters and the likelihood of a
perioperative stroke. We controlled for all other
variables and found that the patients who were first
seen with an acute stroke had over a 5-fold
increased likelihood of an early postoperative
stroke. The patients with DM, AMI, and CHF were
32%, 71%, and 80% more likely, respectively, to suf-
fer an early stroke then the other patients without
these diagnoses. Although there was a trend toward
increased stroke risk with age, this reached statisti-
cal significance only with the group aged 76 to 80
years. These patients were 30% more likely than the
others to experience a postoperative stroke. There
were no differences in the perioperative stroke rates
on the basis of hospital teaching status or geo-
graphic region (data not shown).
Advanced age and comorbidity had a greater
impact on the likelihood of perioperative death
(Table IV). For patients who were more than 75
years of age, the odds of death were increased by 50%
and were doubled for those more than 80 years of
age. Patients who were first seen with an acute stroke
had a 3.5-fold greater likelihood of perioperative
death. Cardiac disease conferred the greatest risk of
perioperative mortality: patients with AMI were 9
times more likely to die and those patients with CHF
were 3 times more likely to die in the postoperative
period than those patients without these diagnoses.
Patients with DM had a 29% increased likelihood of
death, and a diagnosis of hypertension was associated
with a reduced incidence rate of perioperative mor-
tality after CEA. Combined CEA and CAB increased
the perioperative death rate 3-fold. There were no
differences in perioperative death rates on the basis of
the hospital teaching status or the geographic region
(data not shown).
Long-term follow-up. The sample of Medicare
beneficiaries who underwent CEA during the years
1988 to 1990 was followed for a mean period of 3.1
years. During this sampling interval, 6132 patients
died, which represented 27.7% of the total. 
The results of the Cox proportional hazards
model are shown in Table V. The effects of age were
roughly linear with respect to death during the fol-
low-up period, such that those patients who were
more than 80 years of age had more than a 2-fold
greater chance of death. Women were 25% less like-
ly to die than men.
Cardiac comorbidity had a substantial impact on
late outcome. CHF represented the most significant
risk factor for late death, with a hazard ratio of 2.73.
AMI conferred a similar risk of long-term death
(hazard ratio, 2.40), and DM conferred a 51%
increase in the risk of late death. As observed with
the results of perioperative mortality rates, a diagno-
sis of hypertension appeared to confer improved late
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Table III. Impact of age, sex, race, and comorbidity on perioperative stroke after carotid endarterectomy
Parameter Adjusted risk ratio 95% Confidence interval
Age (years) 0.859 - 1.355 
71 to 75 1.079
76 to 80 1.298* 1.024 - 1.646
‡ 81 1.13 0.839 - 1.523
Race: black vs Caucasian 1.165 0.694 - 1.955
Female vs male 1.165 0.975 - 1.393
Diabetes 1.329* 1.054 - 1.677
CHF 1.699† 1.171 - 2.466
Hypertension 1.008 0.833 - 1.220
Acute myocardial infarction 1.714 0.970 - 3.028
Other cardiovascular disease 0.896 0.721 - 1.112
Malignant disease 1.351 0.781 - 2.339
Recent stroke 5.439‡ 4.461 - 6.631
CEA with CAB 0.943 0.470 - 1.890
CHF, Congestive heart failure; CEA, carotid endarterectomy; CAB, coronary artery bypass graft.
Risk ratios are adjusted for covariates. Age categories are compared with patients aged 65 to 70 years. 
*Indicates statistical significance (c 2 test, P < .05).
†P < .01.
‡P < .001.
survival rates after CEA. Malignant disease was pre-
sent in 2% of the sample and was associated with a 2-
fold increase in the long-term death rate. The per-
formance of simultaneous CEA and CAB, which was
associated with greater perioperative mortality rates,
had no impact on long-term survival rates. There
were no differences in late outcome on the basis of
the hospital teaching status or the geographic region
(data not shown).
As a test of the homogeneity in the mortality rates
of our study population, we studied late death rates
separately for each of the years from which our sam-
ple population was drawn (1988 to 1990). There
were no differences observed (data not shown).
DISCUSSION
CEA has been established as a safe and effective
treatment to prevent stroke in patients with signifi-
cant atherosclerosis of the carotid bifurcation.1,2,5
However, the small improvement in the outcome of
CEA versus medical treatment for asymptomatic dis-
ease emphasizes the importance of a low periopera-
tive complication rate and acceptable patient comor-
bidity to confer the benefit of surgery.
Because the perioperative stroke and death rate
after CEA is less than 5% in most recent studies, even
large multicenter trials accrue a relatively small num-
ber of patients with these endpoints, which thereby
limits the statistical analysis of the subgroups. To
overcome this limitation and to examine the rela-
tionship of demographic and comorbid illness para-
meters with surgical outcome, we used a large,
nationwide database of Medicare beneficiaries. 
We found that cardiovascular disease was a
prominent risk factor for poor perioperative and
long-term outcome. AMI increased the likelihood of
perioperative and late death by factors of 9.0 and
2.4, respectively, and CHF contributed to an
increased likelihood of early and late death by factors
of 3.1 and 2.6, respectively. The small group of
patients who underwent combined CAB and CEA
had an increased perioperative mortality rate (likely
as a result of CAB) but no increase in late death
rates. This suggests that patients who undergo com-
bined CAB and CEA have similar long-term survival
rates as those who undergo CEA alone.
It is unclear why CHF contributes to an
increased stroke rate after CEA. CHF may be a
marker for more severe and diffuse cerebrovascular
disease or may capture patients with atrial arrhyth-
mias who are at an increased risk of embolic stroke.
Plecha et al10 documented similar findings in a series
of nearly 10,000 CEAs.
Increasing age also was associated with increased
perioperative death rates after CEA. This finding
was significant for patients who were older than 76
years and especially for those older than 80 years,
who had a 2-fold increased rate of death after
surgery. A recent study by Hsia et al11 is consistent
with our observations. They found a reduction in
the death rate after CEA in all Medicare beneficia-
ries from 3.0% to 1.6% during the period from 1985
to 1996. The death rates for patients who were
more than 84 years of age were twice that of the
patients who were aged 65 to 74 years throughout
the 9-year study. 
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Table IV. Impact of age, sex, race, and comorbidity on perioperative death after carotid endarterectomy
Parameter Adjusted odds ratio 95% Confidence interval
Age (years) 0.924 - 1.511
71 to 75 1.182
76 to 80 1.499* 1.163 - 1.933
‡ 81 2.174† 1.643 - 2.876
Race: black vs Caucasian 1.429 0.827 - 2.469
Female vs male 0.898 0.745 - 1.083
Diabetes 1.330‡ 1.044 - 1.696
CHF 3.085† 2.334 - 4.077
Hypertension 0.641† 0.513 - 0.801
Acute myocardial infarction 9.050† 6.631 - 12.351
Other cardiovascular disease 0.946 0.761 - 1.176
Malignant disease 2.235† 1.431 - 3.491
Recent stroke 3.589† 2.911 - 4.425
CEA with CAB 3.260† 2.214 - 4.799
CHF, Congestive heart failure; CEA, carotid endarterectomy; CAB, coronary artery bypass graft.
Risk ratios for age categories are compared with patients aged 65 to 70 years. 
*P < .01.
†P < .001.
‡Indicates statistical significance (c 2 test, P < .05).
Hsia et al12 from the United States Department
of Health and Human Services also studied the epi-
demiology of CEA between 1985 and 1989 with
Medicare files from the Health Care Financing
Administration. They found a decreasing trend in
the CEAs performed during their study period—the
rate of CEA per 10,000 patients declined from 20.6
in 1985 to 14.2 in 1989. During this period, the
surgical mortality rate decreased from 3.0% to 2.5%,
with an increased risk of death in older patients who
underwent surgery in low-volume hospitals.
Interestingly, high-volume hospitals (ie, greater than
75 CEAs per year) accounted for 25% of all the
CEAs in 1985 but only 16% in 1989. They also
reported that 84% of the patients had TIA or stroke
as presenting symptoms. However, they erroneously
identified these patients with ICD-9-CM diagnostic
codes 433.3 and 433.1, respectively. These codes
actually identify patients with extracranial carotid
artery stenosis generically without regard to symp-
toms. For our analysis, we used codes 362.34, 435,
436, and 437, which encompass patients with amau-
rosis fugax, transient cerebral ischemia, and stroke. 
Several prior reports also have studied the out-
come after CEA for Medicare beneficiaries.
Richardson and Main13 identified 705 patients, who
underwent CEA in 1983 in the state of Kentucky,
with Medicare claims data and chart review. In their
sample, they found a 3.7% incidence rate of periop-
erative stroke and a 2.0% death rate after CEA,
which was similar to our results. They also found an
inverse relationship between a surgeon’s annual case
volume and perioperative stroke. However, 82% of
the patients who underwent operation were
described as having transient cerebral ischemia,
amaurosis fugax, or stroke as compared with 26% in
our study. 
Other contemporaneous reports also highlight
the lower-than-expected proportion of patients
observed in our study who were symptomatic. For
example, in 1989, Callow and Mackey14 reported
on the results of CEA in 619 patients, 71% of whom
were symptomatic. We considered coding omissions
during the preparation of the claim forms as a poten-
tial cause for these results. The undercoding of
chronic illnesses, such as hypertension, has been
documented in Medicare patients15 and is discussed
below. However, of the 5 diagnostic codes available
in our patient database, the first code is reserved for
the primary diagnosis that prompted hospital admis-
sion. Because the hospital compensation is related to
Diagnosis-Related Group classification, it seems less
likely that a TIA or a stroke would be omitted from
the admitting diagnosis than a chronic illness, such
as hypertension. 
We assume that our data are subject to some
undercoding bias related to presenting symptoms.
However, the consistency of the CEA rates for
asymptomatic disease across geographic regions
(data not shown) and hospital types suggests that
many more CEAs were performed for asympto-
matic disease between 1988 and 1990 than previ-
ously reported.
Our results regarding the impact of comorbidity
on outcome also warrant further discussion. A recent
stroke substantially increased the risk of perioperative
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Table V. Impact of age, sex, race, and comorbidity on late death after carotid endarterectomy
Parameter Hazard ratio 95% Confidence interval
Age (years)
71 to 75 1.250* 1.168 - 1.337
76 to 80 1.537* 1.432 - 1.649
‡ 81 2.161* 1.996 - 2.339
Race: black vs Caucasian 1.187† 1.017 - 1.385
Female vs male 0.752* 0.713 - 0.792
Diabetes 1.519* 1.423 - 1.621
CHF 2.569* 2.331 - 2.831
Hypertension 0.865* 0.818 - 0.915
Acute myocardial infarction 2.405* 2.066 - 2.801
Other cardiovascular disease 1.025 0.967 - 1.086
Malignant disease 2.112* 1.844 - 2.420
Recent stroke 1.513* 1.402 - 1.632
CEA with CAB 1.06 0.891 - 1.261
CHF, Congestive heart failure; CEA, carotid endarterectomy; CAB, coronary artery bypass graft.
Hazard ratios for age categories are compared with patients aged 65 to 70 years. 
*P < .001.
†Indicates statistical significance (c 2 test, P < .05).
stroke. The stroke rate for patients who were first
seen with a diagnostic code for a recent stroke was
more than twice that compared with data from the
NASCET trial, which showed a perioperative stroke
risk of 5% in patients who were first seen with a
nondisabling infarction.16 This discrepancy between
the NASCET data and our observations likely result-
ed from coding errors, whereby a preoperative diag-
nosis of recent stroke was carried over for any subse-
quent hospital admission after CEA. This observa-
tion suggests that the other parameters examined for
perioperative stroke risk may be subject to inaccuracy
on the basis of these coding irregularities. 
A diagnosis of hypertension was associated with
a decreased rate of early and late death after CEA.
There are several explanations for this paradoxical
observation. First, the Medicare database in 1988
through 1990 captured only 5 diagnostic codes,
including the primary diagnosis that mandated hos-
pital admission. Therefore, the potential for a coding
bias and omission exists when the patient’s medical
record is examined. Jencks et al15 from the Health
Care Financing Administration have documented
the undercoding of chronic illnesses, especially
hypertension, in patients who were hospitalized,
which was associated with inexplicably lower-than-
average in-hospital death rates. They concluded that
chronic illnesses with high prevalence, such as hyper-
tension, are subject to coding omissions and bias
when insurance claim forms are prepared.
Presumably, patients with fewer comorbidities are
more likely to have hypertension coded, thus
accounting for an improved outcome. The under-
coding was observed in our study because the inci-
dence rate of hypertension (34%) was significantly
less than the 50% to 60% incidence rate that was
documented in the NASCET trial,5 the ACAS
study,2 and in another large series.14
We considered that our data, which examined
comorbidities other than hypertension, may also be
subject to the same coding irregularities. We
observed that CHF had a strong negative impact on
perioperative outcome and on late survival rates.
This diagnostic code was present in 3.7% of our
study group, which is similar to the 5% incidence
rate documented in the VACS.1 Also, 15% of our
sample had the diagnostic code for DM as compared
with 19% in the NASCET study. We therefore con-
cluded that diagnostic coding for DM and CHF was
more consistently applied when compared with
hypertension in our patient sample.
These observations highlight the strengths and
the weaknesses of this large database analysis. As a
result of limited input-field size and coding inefficien-
cies, the MEDPAR files did not accurately capture the
true incidence rate of common diagnoses, such as
hypertension, and may not have accurately identified
all of the patients who were first seen with an acute
stroke or TIA. Because the observed prevalence of
more serious comorbidities, such as AMI, CHF, and
DM, were comparable with other series, the strength
of our study stems from the analysis of short-term and
long-term death rates with respect to these comor-
bidities and age. For patients of ages 65 years and
older, we found that advanced age and medical
comorbidity, particularly active coronary artery dis-
ease, CHF, and DM, were associated with an
increased risk of perioperative and late death. Our
observations may influence the risk-benefit analysis
for CEA in patients who are asymptomatic, particu-
larly octogenarians with 1 or more of these diagnoses.
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